SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Myriad Genetics, Inc. (MYGN)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
2355 65 0 MYGN
Emcee:  s myers Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1430Meldrum: It doesn't MATTER what you say on Tuesday. You have said that youscaram(o)uche-6/18/2005
1429Meldrum: Oh, yeah, here's another excerpt from a post at yahoo....... <scaram(o)uche-6/18/2005
1428Meldrum: My criticism of your silly stance, of painting targets on the backs ofscaram(o)uche-6/18/2005
1427>> Keep that pressure on << This is almost a "Rosenwald-like-ascaram(o)uche-6/17/2005
1426yeah, beer sounds good. italy sounds better. jealousy abounds. :-) Have fun!scaram(o)uche-6/17/2005
1425OT I've been briefly lurking SI for the past few weeks through a couple rouLJM-6/17/2005
1424meldrum: I don't mind large salaries. But I HATE it when it's a low-liscaram(o)uche-6/16/2005
1423Peter's knees are so damned bruised that any old capper will do.scaram(o)uche-6/16/2005
1422brean capping again today??mopgcw-6/16/2005
1421U to Tout Technology to Investors by PR or Business News Wire [not MYGN specifzeta1961-6/16/2005
1420Myriad Genetics Announces Flurizan Phase 2 Results Presentation Conference Call scaram(o)uche-6/15/2005
1419just a quick bit of respect for meldrum, Brean Murray is selling those shares thscaram(o)uche-6/15/2005
1418BMC Mol Biol. 2005 May 13;6(1):12. Characterization of TRZ1, a yeast homolog oscaram(o)uche-6/15/2005
1417Thanks a lot! eomTomato-6/14/2005
14161st albany: MYGN :In-Line 3Q:FY05 Results; Supports Floor For Stock May 4, 200mopgcw-6/14/2005
1415piper but a little dated (sorry have been swamped). MYGN :Reports Better Than Emopgcw-6/14/2005
1414<i>(zeta has asked that I continue to post this stuff, and I'm glad toscaram(o)uche-6/12/2005
1413Rousing recommendation, huh? Thanks.scaram(o)uche-6/11/2005
1412He said they hold mygn and they think it's a promising company to watch. No ewolf-6/11/2005
1411that's pretty much my understanding as well, but the data is soft. makes a scaram(o)uche-6/10/2005
1410Others. I was specifically referring to NSAIDS, such as MYGN's flurbie and tuck-6/10/2005
1409>> and others << are there any others (loose wording, should be somscaram(o)uche-6/10/2005
1408Not sure if this is a problem for flurbie and others, cross posting here: Messatuck-6/10/2005
1407Message 20191383 Panacos is now "Vitex"........ merge, reverse splscaram(o)uche-6/10/2005
1406Neuropeptides. 2005 Jun 3; [Epub ahead of print] The NK1 receptor is involved scaram(o)uche-6/9/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News